Emory University: Research to Revenue

Emory University

Summit Venture Studio

Research to Revenue Report

Summit Venture Studio (SVS) Opportunities

SVS has identified 100 commercialization opportunities from Emory University and scored them based on our proprietary metrics and rubrics.

The SVS model is to identify the top 1% of commercialization opportunities and start companies around them.

Please connect with SVS if you would like to engage with us in our startup and investment efforts.

Return on Research (ROR) Analysis

Commercialization Revenue per Research Dollar

Top Universities by Return on Research (ROR)

ROI Ratio: Commercialization Revenue ÷ Research Funding

University Innovation Analysis

Total Innovation Scores by Institution

Top Universities by Innovation Score

180+ High Innovation

150-179 Strong Innovation

130-149 Moderate Innovation

100-129 Emerging Innovation

130+ total score considered high innovation impact

SVS Innovation Index

Proprietary Assessment of Emory University's Innovation Ecosystem
Score out of 100. Benchmark: Top 50 U.S. research institutions.
A score of 90/100 can be read "doing better than 90% of schools benchmarked"

Innovation Visibility

81/100

Definition: Media mentions, publication count, and global research visibility metrics

Startup Momentum

8/100

Definition: Growth in patents, funding, and startup formation

Ecosystem Strength

44/100

Definition: Tech transfer infrastructure and support systems

Innovation Legacy

A Timeline of Groundbreaking Discoveries

Innovation Timeline

Founded

1836

First Nobel

1997

First Patent

1975

First IPO

N/A

2022-2024

AI-driven drug discovery

2025

Today

Notable Commercialization Outcomes

Nobel Prizes

1980s

HIV Research

Identified HIV virus

1980s

Atlanta Tech

Established Emory Tech Transfer

1995

Flu Vaccine

Developed H1N1 vaccine

2005

Cancer Research

Discovered new cancer drug

2011

Startup Launch

Spun off biotech company

2018

Competitive Benchmarking

Emory University vs. Peer Research Universities

Emory University vs Peers Comparison

Metric	Emory University (FY2023)	Peer Average	Elite Average
Annual R&D Expenditure	$1,094M	$855M	$1,675M
New Inventions Disclosed	24	200	400
Startups Formed	4	7	10
Visibility Index	19	12	23
Licensing Revenue	$25M	$17M	$46M

Note: Peer Average = Median value among U.S. R1 research universities. Elite Average = Top 10 ranked U.S. research universities.

Emerging Opportunities

1. AI-Driven Cancer Diagnostics Revolutionizing Early Detection and Treatment

Emory’s AI technology improves early cancer detection accuracy, reducing mortality rates and enabling scalable, cost-effective diagnostics in global healthcare markets.

2. Immunotherapy Innovations Targeting Resistant Cancers for Enhanced Patient Outcomes

Emory’s novel immunotherapy treatments address treatment-resistant cancers, offering scalable, personalized solutions with strong competitive advantages in oncology therapeutics.

3. Next-Gen Neurotechnology for Brain Disorder Monitoring and Intervention

Emory’s neurotech platforms enable real-time brain disorder detection and intervention, addressing growing neurological disease markets with scalable, non-invasive solutions.

4. Advanced Biomaterials Enabling Regenerative Medicine and Tissue Engineering

Emory develops biomaterials that accelerate tissue regeneration, offering scalable, cost-effective solutions for chronic wound care and surgical repair markets.

5. Precision Medicine Platforms Integrating Genomics and Big Data Analytics

Emory’s precision medicine tools leverage genomics and AI, enabling scalable, personalized treatment plans that improve patient outcomes and reduce healthcare costs.

6. Sustainable Bioprocessing Technologies for Biofuel and Biochemical Production

Emory’s bioprocessing innovations enable efficient, scalable biofuel production, addressing energy sustainability challenges with competitive cost and environmental advantages.